Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FRMD4A antisense RNA 1 (FRMD4A-AS1), also called AL157392.2, is a long non-coding antisense RNA gene transcribed from the human genome opposite the FRMD4A gene locus. FRMD4A-AS1 does not code for a protein and is considered a non-coding transcript. The biological functions and significance of FRMD4A-AS1 have not yet been detailed in the scientific literature, and there are no known links to diseases, mechanisms of action, or drug interactions. Its general class, long non-coding antisense RNA, may suggest possible regulatory effects on the sense FRMD4A gene, but no data specific to FRMD4A-AS1 has been published or reported[4].
None reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FRMD4A antisense RNA 1 (FRMD4A-AS1).